Skip to content

Revvity RVTY Diagnostics — Restructuring and Other Costs (Income)

Other segment segments

Life Sciences
$3.23M+27.7%

Similar metrics at other companies

TEC
TECHDiagnostics And Genomics — Restructuring Costs Net Of Adjustments
$137K-60.8%
TEC
TECHDiagnostics And Spatial Biology — Restructuring Charges
$27K
TEC
TECHDiagnostics And Spatial Biology — Restructuring Costs Net Of Adjustments
-$19K-103%
Labcorp Holdings logo
LHLab Corp Diagnostics — Restructuring Charges
$2M+17.6%
TEC
TECHDiagnostics And Genomics — Restructuring Charges
$14K
Labcorp Holdings logo
LHLab Corp Diagnostics — Net Restructuring Charges
$3.3M+106%

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$11.16B-22.9%
Enterprise value$14.24B-13.7%
P/E46.5×-4.0×
P/S3.8×-1.4×

Profitability

See full
Gross margin48.5%
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCosts.

The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revvity's diagnostics — restructuring and other costs (income).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Revvity's diagnostics — restructuring and other costs (income)?
Revvity (RVTY) reported diagnostics — restructuring and other costs (income) of $7.55M in Q1 2026.
How has Revvity's diagnostics — restructuring and other costs (income) changed year-over-year?
Revvity's diagnostics — restructuring and other costs (income) increased by 5495.6% year-over-year, from $135K to $7.55M.
What does diagnostics — restructuring and other costs (income) mean?
One-time costs or gains associated with reorganizing the diagnostics business segment.
How do you interpret diagnostics — restructuring and other costs (income)?
High costs suggest significant operational transformation, while consistent low levels indicate organizational stability.
How does diagnostics — restructuring and other costs (income) compare across companies?
Commonly reported by large-cap industrial and healthcare companies undergoing periodic operational optimization.